{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:12:48Z","timestamp":1783930368223,"version":"3.55.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National High Level Hospital Clinical Research Fundin","award":["BJ-2023-199"],"award-info":[{"award-number":["BJ-2023-199"]}]},{"name":"Research project on high quality development of Hospital pharmacy, National Institute of Hospital Administration, NHC, China","award":["NIHAYSZX2536"],"award-info":[{"award-number":["NIHAYSZX2536"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00228-026-04116-5","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:40:47Z","timestamp":1781754047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial-induced hyponatremia: pathophysiological mechanisms, implicated agents, and clinical management strategies"],"prefix":"10.1007","volume":"82","author":[{"given":"Tianqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9461-0453","authenticated-orcid":false,"given":"Pengfei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"6","key":"4116_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00467-013-2712-4","volume":"29","author":"E Scurati-Manzoni","year":"2014","unstructured":"Scurati-Manzoni E, Fossali EF, Agostoni C, Riva E, Simonetti GD, Zanolari-Calderari M et al (2014) Electrolyte abnormalities in cystic fibrosis: systematic review of the literature. Pediatr Nephrol 29(6):1015\u20131023. https:\/\/doi.org\/10.1007\/s00467-013-2712-4","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"4116_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.amjmed.2009.01.027","volume":"122","author":"SS Waikar","year":"2009","unstructured":"Waikar SS, Mount DB, Curhan GC (2009) Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 122(9):857\u2013865. https:\/\/doi.org\/10.1016\/j.amjmed.2009.01.027","journal-title":"Am J Med"},{"issue":"3","key":"4116_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jama.2022.11176","volume":"328","author":"HJ Adrogu\u00e9","year":"2022","unstructured":"Adrogu\u00e9 HJ, Tucker BM, Madias NE (2022) Diagnosis and management of hyponatremia: a review. JAMA 328(3):280\u2013291. https:\/\/doi.org\/10.1001\/jama.2022.11176","journal-title":"JAMA"},{"key":"4116_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000493235","volume":"52","author":"A Peri","year":"2019","unstructured":"Peri A (2019) Morbidity and mortality of hyponatremia. Front Horm Res 52:36\u201348. https:\/\/doi.org\/10.1159\/000493235","journal-title":"Front Horm Res"},{"issue":"8","key":"4116_CR5","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.amjmed.2019.12.056","volume":"133","author":"V Su\u00e1rez","year":"2020","unstructured":"Su\u00e1rez V, Norello D, Sen E, Todorova P, Hackl MJ, H\u00fcser C et al (2020) Impairment of neurocognitive functioning, motor performance, and mood stability in hospitalized patients with euvolemic moderate and profound hyponatremia. Am J Med 133(8):986\u201393e5. https:\/\/doi.org\/10.1016\/j.amjmed.2019.12.056","journal-title":"Am J Med"},{"issue":"4","key":"4116_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/eci.12597","volume":"46","author":"F Vandergheynst","year":"2016","unstructured":"Vandergheynst F, Gombeir Y, Bellante F, Perrotta G, Remiche G, M\u00e9lot C et al (2016) Impact of hyponatremia on nerve conduction and muscle strength. Eur J Clin Invest 46(4):328\u2013333. https:\/\/doi.org\/10.1111\/eci.12597","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"4116_CR7","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1210\/jc.2015-1261","volume":"100","author":"RL Usala","year":"2015","unstructured":"Usala RL, Fernandez SJ, Mete M, Cowen L, Shara NM, Barsony J et al (2015) Hyponatremia is associated with increased osteoporosis and bone fractures in a large US health system population. J Clin Endocrinol Metab 100(8):3021\u20133031. https:\/\/doi.org\/10.1210\/jc.2015-1261","journal-title":"J Clin Endocrinol Metab"},{"key":"4116_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000493237","volume":"52","author":"J Barsony","year":"2019","unstructured":"Barsony J, Kleess L, Verbalis JG (2019) Hyponatremia is linked to bone loss, osteoporosis, fragility and bone fractures. Front Horm Res 52:49\u201360. https:\/\/doi.org\/10.1159\/000493237","journal-title":"Front Horm Res"},{"issue":"1","key":"4116_CR9","first-page":"1","volume":"39","author":"AM Ramos-Levi","year":"2014","unstructured":"Ramos-Levi AM, Duran Rodriguez-Hervada A, Mendez-Bailon M, Marco-Martinez J (2014) Drug-induced hyponatremia: an updated review. Minerva Endocrinol 39(1):1\u201312","journal-title":"Minerva Endocrinol"},{"key":"4116_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2025.05.024","author":"C Ben Salem","year":"2025","unstructured":"Ben Salem C, Sahnoun D (2025) Drug-induced hyponatremia in clinical care. Eur J Intern Med. https:\/\/doi.org\/10.1016\/j.ejim.2025.05.024","journal-title":"Eur J Intern Med"},{"issue":"1","key":"4116_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40780-025-00463-0","volume":"11","author":"R Takata","year":"2025","unstructured":"Takata R, Taga M, Nagai H, Nishita Y, Kobayashi H, Arakawa N et al (2025) Risk factors for linezolid-associated hyponatremia focused on differences between intravenous and oral administration: a single-center, retrospective study. J Pharm health care Sci 11(1):53. https:\/\/doi.org\/10.1186\/s40780-025-00463-0","journal-title":"J Pharm health care Sci"},{"issue":"4","key":"4116_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.nefro.2017.03.021","volume":"37","author":"G Spasovski","year":"2017","unstructured":"Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D et al (2017) Hyponatraemia diagnosis and treatment clinical practice guidelines. Nefrologia 37(4):370\u2013380. https:\/\/doi.org\/10.1016\/j.nefro.2017.03.021","journal-title":"Nefrologia"},{"key":"4116_CR13","doi-asserted-by":"publisher","unstructured":"Kim GH (2022) Pathophysiology of drug-induced hyponatremia. J Clin Med 11(19). https:\/\/doi.org\/10.3390\/jcm11195810","DOI":"10.3390\/jcm11195810"},{"issue":"20","key":"4116_CR14","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1056\/NEJMcp066837","volume":"356","author":"DH Ellison","year":"2007","unstructured":"Ellison DH, Berl T (2007) Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 356(20):2064\u20132072","journal-title":"N Engl J Med"},{"key":"4116_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000493246","volume":"52","author":"G Liamis","year":"2019","unstructured":"Liamis G, Megapanou E, Elisaf M, Milionis H (2019) Hyponatremia-inducing drugs. Front Horm Res 52:167\u2013177","journal-title":"Front Horm Res"},{"issue":"6","key":"4116_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0897190014546836","volume":"27","author":"KA Wargo","year":"2014","unstructured":"Wargo KA, Edwards JD (2014) Aminoglycoside-induced nephrotoxicity. J Pharm Pract 27(6):573\u2013577. https:\/\/doi.org\/10.1177\/0897190014546836","journal-title":"J Pharm Pract"},{"issue":"8","key":"4116_CR17","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.ki.5002776","volume":"73","author":"E Gonz\u00e1lez","year":"2008","unstructured":"Gonz\u00e1lez E, Guti\u00e9rrez E, Galeano C, Chevia C, de Sequera P, Bernis C et al (2008) Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 73(8):940\u2013946. https:\/\/doi.org\/10.1038\/sj.ki.5002776","journal-title":"Kidney Int"},{"issue":"4","key":"4116_CR18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.pcl.2016.04.007","volume":"63","author":"DM Goetz","year":"2016","unstructured":"Goetz DM, Singh S (2016) Respiratory system disease. Pediatr Clin North Am 63(4):637\u2013659. https:\/\/doi.org\/10.1016\/j.pcl.2016.04.007","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"4116_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00228-015-1865-4","volume":"71","author":"A Ordooei Javan","year":"2015","unstructured":"Ordooei Javan A, Shokouhi S, Sahraei Z (2015) A review on colistin nephrotoxicity. Eur J Clin Pharmacol 71(7):801\u2013810. https:\/\/doi.org\/10.1007\/s00228-015-1865-4","journal-title":"Eur J Clin Pharmacol"},{"key":"4116_CR20","doi-asserted-by":"publisher","unstructured":"Scoglio M, Bronz G, Rinoldi PO, Far\u00e9 PB, Betti C, Bianchetti MG et al (2021) Electrolyte and acid-base disorders triggered by aminoglycoside or colistin therapy: a systematic review. Antibiot 10(2). https:\/\/doi.org\/10.3390\/antibiotics10020140","DOI":"10.3390\/antibiotics10020140"},{"issue":"1","key":"4116_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1074\/jbc.M109959200","volume":"277","author":"C Schmitz","year":"2002","unstructured":"Schmitz C, Hilpert J, Jacobsen C, Boensch C, Christensen EI, Luft FC et al (2002) Megalin deficiency offers protection from renal aminoglycoside accumulation. J Biol Chem 277(1):618\u2013622. https:\/\/doi.org\/10.1074\/jbc.M109959200","journal-title":"J Biol Chem"},{"issue":"12","key":"4116_CR22","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1128\/aac.00254-13","volume":"57","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Yamaguchi H, Ogura J, Kobayashi M, Yamada T, Iseki K (2013) Megalin contributes to kidney accumulation and nephrotoxicity of colistin. Antimicrob Agents Chemother 57(12):6319\u20136324. https:\/\/doi.org\/10.1128\/aac.00254-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"4116_CR23","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","volume":"8","author":"RE Campbell","year":"2023","unstructured":"Campbell RE, Chen CH, Edelstein CL (2023) Overview of antibiotic-induced nephrotoxicity. Kidney Int Rep 8(11):2211\u20132225. https:\/\/doi.org\/10.1016\/j.ekir.2023.08.031","journal-title":"Kidney Int Rep"},{"issue":"1","key":"4116_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ki.2010.337","volume":"79","author":"JM Lopez-Novoa","year":"2011","unstructured":"Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ (2011) New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 79(1):33\u201345. https:\/\/doi.org\/10.1038\/ki.2010.337","journal-title":"Kidney Int"},{"issue":"7","key":"4116_CR25","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1128\/aac.00070-14","volume":"58","author":"C Dai","year":"2014","unstructured":"Dai C, Li J, Tang S, Li J, Xiao X (2014) Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways. Antimicrob Agents Chemother 58(7):4075\u20134085. https:\/\/doi.org\/10.1128\/aac.00070-14","journal-title":"Antimicrob Agents Chemother"},{"key":"4116_CR26","doi-asserted-by":"publisher","unstructured":"Nation RL, Rigatto MHP, Falci DR, Zavascki AP (2019) Polymyxin acute kidney injury: dosing and other strategies to reduce toxicity. Antibiot 8(1). https:\/\/doi.org\/10.3390\/antibiotics8010024","DOI":"10.3390\/antibiotics8010024"},{"issue":"1","key":"4116_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0003-9861(80)90103-4","volume":"205","author":"JM Weinberg","year":"1980","unstructured":"Weinberg JM, Harding PG, Humes HD (1980) Mechanisms of gentamicin-induced dysfunction of renal cortical mitochondria. II. Effects on mitochondrial monovalent cation transport. Arch Biochem Biophys 205(1):232\u2013239. https:\/\/doi.org\/10.1016\/0003-9861(80)90103-4","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"4116_CR28","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/sj.ki.5001654","volume":"70","author":"MC Sassen","year":"2006","unstructured":"Sassen MC, Kim SW, Kwon TH, Knepper MA, Miller RT, Fr\u00f8kiaer J et al (2006) Dysregulation of renal sodium transporters in gentamicin-treated rats. Kidney Int 70(6):1026\u20131037. https:\/\/doi.org\/10.1038\/sj.ki.5001654","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"4116_CR29","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.nephro.2017.01.014","volume":"13","author":"F Emma","year":"2017","unstructured":"Emma F, Salviati L (2017) Mitochondrial cytopathies and the kidney. Nephrologie therapeutique 13(Suppl 1):S23\u2013s8. https:\/\/doi.org\/10.1016\/j.nephro.2017.01.014","journal-title":"Nephrologie therapeutique"},{"issue":"1","key":"4116_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","volume":"15","author":"FM Hannan","year":"2018","unstructured":"Hannan FM, Kallay E, Chang W, Brandi ML, Thakker RV (2018) The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat reviews Endocrinol 15(1):33\u201351. https:\/\/doi.org\/10.1038\/s41574-018-0115-0","journal-title":"Nat reviews Endocrinol"},{"issue":"4","key":"4116_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneph.2009.17","volume":"5","author":"R Zietse","year":"2009","unstructured":"Zietse R, Zoutendijk R, Hoorn EJ (2009) Fluid, electrolyte and acid-base disorders associated with antibiotic therapy. Nat Rev Nephrol 5(4):193\u2013202. https:\/\/doi.org\/10.1038\/nrneph.2009.17","journal-title":"Nat Rev Nephrol"},{"issue":"21","key":"4116_CR32","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1016\/0006-2952(83)90206-x","volume":"32","author":"JH Powell","year":"1983","unstructured":"Powell JH, Reidenberg MM (1983) Further studies of the response of kidney lysosomes to aminoglycosides and other cations. Biochem Pharmacol 32(21):3213\u20133220. https:\/\/doi.org\/10.1016\/0006-2952(83)90206-x","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"4116_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/ki.2011.400","volume":"81","author":"AS Geara","year":"2012","unstructured":"Geara AS, Parikh A, Rekhtman Y, Rao MK (2012) The Case \u2223 Metabolic alkalosis in a patient with cystic fibrosis. Kidney Int 81(4):421\u2013422. https:\/\/doi.org\/10.1038\/ki.2011.400","journal-title":"Kidney Int"},{"issue":"8","key":"4116_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2169\/internalmedicine.42.665","volume":"42","author":"H Mori","year":"2003","unstructured":"Mori H, Kuroda Y, Imamura S, Toyoda A, Yoshida I, Kawakami M et al (2003) Hyponatremia and\/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole. Intern Med (Tokyo Japan) 42(8):665\u2013669. https:\/\/doi.org\/10.2169\/internalmedicine.42.665","journal-title":"Intern Med (Tokyo Japan)"},{"issue":"3\u20134","key":"4116_CR35","doi-asserted-by":"publisher","first-page":"p51","DOI":"10.1159\/000089682","volume":"102","author":"S Muto","year":"2006","unstructured":"Muto S, Tsuruoka S, Miyata Y, Fujimura A, Kusano E (2006) Effect of trimethoprim-sulfamethoxazole on Na and K+ transport properties in the rabbit cortical collecting duct perfused in vitro. Nephron Physiol 102(3\u20134):p51\u201360. https:\/\/doi.org\/10.1159\/000089682","journal-title":"Nephron Physiol"},{"issue":"1","key":"4116_CR36","first-page":"45","volume":"55","author":"BR Don","year":"2001","unstructured":"Don BR (2001) The effect of trimethoprim on potassium and uric acid metabolism in normal human subjects. Clin Nephrol 55(1):45\u201352","journal-title":"Clin Nephrol"},{"issue":"3","key":"4116_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2165\/00002018-200022030-00006","volume":"22","author":"MA Perazella","year":"2000","unstructured":"Perazella MA (2000) Trimethoprim-induced hyperkalemia: clinical data, mechanism, prevention and management. Drug Saf 22(3):227\u2013236","journal-title":"Drug Saf"},{"issue":"5","key":"4116_CR38","doi-asserted-by":"publisher","first-page":"F1076","DOI":"10.1152\/ajprenal.00075.2004","volume":"287","author":"J Song","year":"2004","unstructured":"Song J, Hu X, Khan O, Tian Y, Verbalis JG, Ecelbarger CA (2004) Increased blood pressure, aldosterone activity, and regional differences in renal ENaC protein during vasopressin escape. Am J Physiol Ren Physiol 287(5):F1076\u2013F1083. https:\/\/doi.org\/10.1152\/ajprenal.00075.2004","journal-title":"Am J Physiol Ren Physiol"},{"issue":"6","key":"4116_CR39","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1345\/aph.1D573","volume":"38","author":"BA Hemstreet","year":"2004","unstructured":"Hemstreet BA (2004) Antimicrobial-associated renal tubular acidosis. Annals pharmacotherapy 38(6):1031\u20131038. https:\/\/doi.org\/10.1345\/aph.1D573","journal-title":"Annals pharmacotherapy"},{"issue":"12","key":"4116_CR40","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.amjmed.2016.07.012","volume":"129","author":"D Tsapepas","year":"2016","unstructured":"Tsapepas D, Chiles M, Babayev R, Rao MK, Jaitly M, Salerno D et al (2016) Incidence of hyponatremia with high-dose trimethoprim-sulfamethoxazole exposure. Am J Med 129(12):1322\u20131328. https:\/\/doi.org\/10.1016\/j.amjmed.2016.07.012","journal-title":"Am J Med"},{"issue":"9","key":"4116_CR41","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/jcpt.13679","volume":"47","author":"S Yokoyama","year":"2022","unstructured":"Yokoyama S, Nakagawa J, Aiuchi N, Seito T, Niioka T (2022) Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate. J Clin Pharm Ther 47(9):1409\u20131417. https:\/\/doi.org\/10.1111\/jcpt.13679","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"4116_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.7326\/0003-4819-119-4-199308150-00007","volume":"119","author":"S Greenberg","year":"1993","unstructured":"Greenberg S, Reiser IW, Chou SY, Porush JG (1993) Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. Ann Intern Med 119(4):291\u2013295. https:\/\/doi.org\/10.7326\/0003-4819-119-4-199308150-00007","journal-title":"Ann Intern Med"},{"issue":"4","key":"4116_CR43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.7326\/0003-4819-119-4-199308150-00008","volume":"119","author":"H Vel\u00e1zquez","year":"1993","unstructured":"Vel\u00e1zquez H, Perazella MA, Wright FS, Ellison DH (1993) Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med 119(4):296\u2013301. https:\/\/doi.org\/10.7326\/0003-4819-119-4-199308150-00008","journal-title":"Ann Intern Med"},{"issue":"5","key":"4116_CR44","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4140\/TCP.n.2011.342","volume":"26","author":"RL Dunn","year":"2011","unstructured":"Dunn RL, Smith WJ, Stratton MA (2011) Trimethoprim-sulfamethoxazole-induced hyponatremia. Consultant pharmacist: J Am Soc Consultant Pharmacists 26(5):342\u2013349. https:\/\/doi.org\/10.4140\/TCP.n.2011.342","journal-title":"Consultant pharmacist: J Am Soc Consultant Pharmacists"},{"issue":"10","key":"4116_CR45","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1177\/1060028013502457","volume":"47","author":"SM Babar","year":"2013","unstructured":"Babar SM (2013) SIADH associated with ciprofloxacin. Annals pharmacotherapy 47(10):1359\u20131363. https:\/\/doi.org\/10.1177\/1060028013502457","journal-title":"Annals pharmacotherapy"},{"issue":"21","key":"4116_CR46","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.2146\/ajhp150208","volume":"72","author":"SH Baik","year":"2015","unstructured":"Baik SH, Choi YK, Kim HS, Yoon YK, Sohn JW, Kim MJ (2015) A probable case of syndrome of inappropriate antidiuretic hormone secretion associated with linezolid. Am J health-system pharmacy: AJHP : official J Am Soc Health-System Pharmacists 72(21):1865\u20131869. https:\/\/doi.org\/10.2146\/ajhp150208","journal-title":"Am J health-system pharmacy: AJHP : official J Am Soc Health-System Pharmacists"},{"issue":"3","key":"4116_CR47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jcpt.12681","volume":"43","author":"P Ioannou","year":"2018","unstructured":"Ioannou P, Stavroulaki M, Mavrikaki V, Papakitsou I, Panagiotakis S (2018) A case of severe hyponatremia due to linezolid-induced SIADH. J Clin Pharm Ther 43(3):434\u2013436. https:\/\/doi.org\/10.1111\/jcpt.12681","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"4116_CR48","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/jcpt.13069","volume":"45","author":"SVK Singhania","year":"2020","unstructured":"Singhania SVK, Shenoy S, Kapoor D (2020) Linezolid-induced rare triad of hypoglycaemia, bone marrow suppression and hyponatraemia in elderly. J Clin Pharm Ther 45(2):376\u2013378. https:\/\/doi.org\/10.1111\/jcpt.13069","journal-title":"J Clin Pharm Ther"},{"issue":"10","key":"4116_CR49","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1248\/bpb.b23-00038","volume":"46","author":"R Tanaka","year":"2023","unstructured":"Tanaka R, Morinaga Y, Iwao M, Tatsuta R, Hashimoto T, Hiramatsu K et al (2023) Comparison of incidence of hyponatremia between linezolid and vancomycin by propensity score matching analysis. Biol Pharm Bull 46(10):1365\u20131370. https:\/\/doi.org\/10.1248\/bpb.b23-00038","journal-title":"Biol Pharm Bull"},{"key":"4116_CR50","doi-asserted-by":"publisher","unstructured":"Shibata Y, Hagihara M, Asai N, Shiota A, Hirai J, Mori N et al (2023) A retrospective study to compare the incidence of hyponatremia after administration between linezolid and tedizolid. Antibiot 12(2). https:\/\/doi.org\/10.3390\/antibiotics12020345","DOI":"10.3390\/antibiotics12020345"},{"issue":"12","key":"4116_CR51","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1248\/bpb.b16-00418","volume":"39","author":"R Tanaka","year":"2016","unstructured":"Tanaka R, Suzuki Y, Takumi Y, Iwao M, Sato Y, Hashinaga K et al (2016) A retrospective analysis of risk factors for linezolid-associated hyponatremia in Japanese patients. Biol Pharm Bull 39(12):1968\u20131973. https:\/\/doi.org\/10.1248\/bpb.b16-00418","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"4116_CR52","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/jcpt.13287","volume":"46","author":"R Tanaka","year":"2021","unstructured":"Tanaka R, Suzuki Y, Morinaga Y, Iwao M, Takumi Y, Hashinaga K et al (2021) A retrospective test for a possible relationship between linezolid-induced thrombocytopenia and hyponatraemia. J Clin Pharm Ther 46(2):343\u2013351. https:\/\/doi.org\/10.1111\/jcpt.13287","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"4116_CR53","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejim.2012.10.014","volume":"24","author":"K Olsson","year":"2013","unstructured":"Olsson K, \u00d6hlin B, Melander O (2013) Epidemiology and characteristics of hyponatremia in the emergency department. Eur J Intern Med 24(2):110\u2013116. https:\/\/doi.org\/10.1016\/j.ejim.2012.10.014","journal-title":"Eur J Intern Med"},{"issue":"7","key":"4116_CR54","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00228-020-03086-6","volume":"77","author":"B Mannheimer","year":"2021","unstructured":"Mannheimer B, Bergh CF, Falhammar H, Calissendorff J, Skov J, Lindh JD (2021) Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia. Eur J Clin Pharmacol 77(7):1049\u20131055. https:\/\/doi.org\/10.1007\/s00228-020-03086-6","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"4116_CR55","doi-asserted-by":"publisher","first-page":"102525","DOI":"10.1016\/j.jiac.2024.09.014","volume":"31","author":"Y Shibata","year":"2025","unstructured":"Shibata Y, Hirai J, Mori N, Asai N, Hagihara M, Yamada Y et al (2025) Comparison of incidence of hyponatremia between linezolid and vancomycin in neonates and infants. J Infect chemotherapy: official J Japan Soc Chemother 31(1):102525. https:\/\/doi.org\/10.1016\/j.jiac.2024.09.014","journal-title":"J Infect chemotherapy: official J Japan Soc Chemother"},{"issue":"5","key":"4116_CR56","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/01480545.2023.2240036","volume":"47","author":"NHA Hussen","year":"2024","unstructured":"Hussen NHA, Qadir SH, Rahman HS, Hamalaw YY, Kareem PSS, Hamza BA (2024) Long-term toxicity of fluoroquinolones: a comprehensive review. Drug Chem Toxicol 47(5):795\u2013806. https:\/\/doi.org\/10.1080\/01480545.2023.2240036","journal-title":"Drug Chem Toxicol"},{"issue":"7","key":"4116_CR57","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejim.2004.08.003","volume":"15","author":"D Adler","year":"2004","unstructured":"Adler D, Voide C, Thorens JB, Desmeules J (2004) SIADH consecutive to ciprofloxacin intake. Eur J Intern Med 15(7):463\u2013464. https:\/\/doi.org\/10.1016\/j.ejim.2004.08.003","journal-title":"Eur J Intern Med"},{"issue":"10","key":"4116_CR58","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1345\/aph.10359","volume":"35","author":"JM Kushner","year":"2001","unstructured":"Kushner JM, Peckman HJ, Snyder CR (2001) Seizures associated with fluoroquinolones. Annals pharmacotherapy 35(10):1194\u20131198. https:\/\/doi.org\/10.1345\/aph.10359","journal-title":"Annals pharmacotherapy"},{"issue":"1","key":"4116_CR59","doi-asserted-by":"publisher","first-page":"010803","DOI":"10.11613\/bm.2024.010803","volume":"34","author":"L \u0160vitek","year":"2024","unstructured":"\u0160vitek L, Grubi\u0161i\u0107 B, Schonberger E, Zlosa M, Sabadi D, Li\u0161nji\u0107 D et al (2024) Syndrome of inappropriate antidiuretic hormone secretion as an adverse reaction of ciprofloxacin: a case report and literature review. Biochemia Med 34(1):010803. https:\/\/doi.org\/10.11613\/bm.2024.010803","journal-title":"Biochemia Med"},{"issue":"6","key":"4116_CR60","doi-asserted-by":"publisher","first-page":"e684","DOI":"10.1097\/mjt.0000000000000642","volume":"25","author":"V Kumar","year":"2018","unstructured":"Kumar V, Malhotra I, Shankar S, Kupfer Y (2018) Syndrome of inappropriate antidiuretic hormone consecutive to treatment with ciprofloxacin. Am J Ther 25(6):e684\u2013e5. https:\/\/doi.org\/10.1097\/mjt.0000000000000642","journal-title":"Am J Ther"},{"key":"4116_CR61","doi-asserted-by":"publisher","first-page":"5434230","DOI":"10.1155\/2016\/5434230","volume":"2016","author":"M Mocan","year":"2016","unstructured":"Mocan M, Blaga SN (2016) Severe hyponatremia due to levofloxacin treatment for pseudomonas aeruginosa community-acquired pneumonia in a patient with oropharyngeal cancer. Case Rep Med 2016:5434230. https:\/\/doi.org\/10.1155\/2016\/5434230","journal-title":"Case Rep Med"},{"issue":"Suppl3","key":"4116_CR62","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.4103\/2230-8210.84870","volume":"15","author":"BP Pillai","year":"2011","unstructured":"Pillai BP, Unnikrishnan AG, Pavithran PV (2011) Syndrome of inappropriate antidiuretic hormone secretion: Revisiting a classical endocrine disorder. Indian J Endocrinol Metab 15(Suppl3):S208\u2013S215. https:\/\/doi.org\/10.4103\/2230-8210.84870","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"4116_CR63","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.1038\/s41598-022-14387-4","volume":"12","author":"E Perell\u00f3-Camacho","year":"2022","unstructured":"Perell\u00f3-Camacho E, Pomares-G\u00f3mez FJ, L\u00f3pez-Penabad L, Mirete-L\u00f3pez RM, Pinedo-Esteban MR, Dom\u00ednguez-Escribano JR (2022) Clinical efficacy of urea treatment in syndrome of inappropriate antidiuretic hormone secretion. Sci Rep 12(1):10266. https:\/\/doi.org\/10.1038\/s41598-022-14387-4","journal-title":"Sci Rep"},{"issue":"Spec No","key":"4116_CR64","doi-asserted-by":"publisher","first-page":"131s","DOI":"10.1111\/j.1469-445x.2000.tb00016.x","volume":"85","author":"JF Morris","year":"2000","unstructured":"Morris JF, Christian H, Ma D, Wang H (2000) Dendritic secretion of peptides from hypothalamic magnocellular neurosecretory neurones: a local dynamic control system and its functions. Exp Physiol 85(Spec No):131s\u20138s. https:\/\/doi.org\/10.1111\/j.1469-445x.2000.tb00016.x","journal-title":"Exp Physiol"},{"key":"4116_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","volume":"1508","author":"DA Enoch","year":"2017","unstructured":"Enoch DA, Yang H, Aliyu SH, Micallef C (2017) The changing epidemiology of invasive fungal infections. Methods in molecular biology. (Clifton NJ) 1508:17\u201365. https:\/\/doi.org\/10.1007\/978-1-4939-6515-1_2","journal-title":"(Clifton NJ)"},{"key":"4116_CR66","doi-asserted-by":"publisher","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K et al (2018) Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and. 24(Suppl 1):e1\u2013e38. https:\/\/doi.org\/10.1016\/j.cmi.2018.01.002","DOI":"10.1016\/j.cmi.2018.01.002"},{"key":"4116_CR67","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cca.2013.05.025","volume":"424","author":"Y Suzuki","year":"2013","unstructured":"Suzuki Y, Tokimatsu I, Sato Y, Kawasaki K, Sato Y, Goto T et al (2013) Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity. Clin Chim Acta 424:119\u2013122. https:\/\/doi.org\/10.1016\/j.cca.2013.05.025","journal-title":"Clin Chim Acta"},{"issue":"1","key":"4116_CR68","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/13693786.2011.587210","volume":"50","author":"KH Kim","year":"2012","unstructured":"Kim KH, Lee S, Lee S, Yun NR, Kim NJ, Yu KS et al (2012) Voriconazole-associated severe hyponatremia. Med Mycol 50(1):103\u2013105. https:\/\/doi.org\/10.3109\/13693786.2011.587210","journal-title":"Med Mycol"},{"issue":"5","key":"4116_CR69","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1128\/aac.00146-13","volume":"57","author":"RA Xu","year":"2013","unstructured":"Xu RA, Lin GY, Hu LF, Shi DW, Ye XL, Liu YJ et al (2013) Successful management of voriconazole-associated hyponatremia with therapeutic drug monitoring. Antimicrob Agents Chemother 57(5):2422\u20132423. https:\/\/doi.org\/10.1128\/aac.00146-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"4116_CR70","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s10096-012-1690-y","volume":"31","author":"J Cadranel","year":"2012","unstructured":"Cadranel J, Philippe B, Hennequin C, Bergeron A, Bergot E, Bourdin A et al (2012) Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. Eur J Clin Microbiol Infect diseases: official publication Eur Soc Clin Microbiol 31(11):3231\u20133239. https:\/\/doi.org\/10.1007\/s10096-012-1690-y","journal-title":"Eur J Clin Microbiol Infect diseases: official publication Eur Soc Clin Microbiol"},{"issue":"5","key":"4116_CR71","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/1120009x.2017.1323395","volume":"29","author":"S Ho","year":"2017","unstructured":"Ho S, Rawlins M, Ingram P, Boan P (2017) Voriconazole-induced hyponatraemia associated with homozygous CYP2C19*2 genotype. J Chemother 29(5):325\u2013326. https:\/\/doi.org\/10.1080\/1120009x.2017.1323395","journal-title":"J Chemother"},{"issue":"11","key":"4116_CR72","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/ctr.12834","volume":"30","author":"MT Levine","year":"2016","unstructured":"Levine MT, Chandrasekar PH (2016) Adverse effects of voriconazole: over a decade of use. Clin Transplant 30(11):1377\u20131386. https:\/\/doi.org\/10.1111\/ctr.12834","journal-title":"Clin Transplant"},{"issue":"6","key":"4116_CR73","first-page":"489","volume":"45","author":"K Isobe","year":"2007","unstructured":"Isobe K, Muraoka S, Sugino K, Yamazaki Y, Kikuchi N, Hamanaka N et al (2007) [Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy]. Nihon Kokyuki Gakkai zasshi = J Japanese Respiratory Soc 45(6):489\u2013493","journal-title":"Nihon Kokyuki Gakkai zasshi = J Japanese Respiratory Soc"},{"issue":"4","key":"4116_CR74","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10157-010-0305-0","volume":"14","author":"J Teranishi","year":"2010","unstructured":"Teranishi J, Nagatoya K, Kakita T, Yamauchi Y, Matsuda H, Mori T et al (2010) Voriconazole-associated salt-losing nephropathy. Clin Exp Nephrol 14(4):377\u2013380. https:\/\/doi.org\/10.1007\/s10157-010-0305-0","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"4116_CR75","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jcph.2381","volume":"64","author":"L Cheng","year":"2024","unstructured":"Cheng L, Liu Z, Yu M, Lin L, Xiong L, Dai Q (2024) Hypokalemia and hyponatremia in adult patients receiving voriconazole therapeutic drug monitoring. J Clin Pharmacol 64(4):461\u2013468. https:\/\/doi.org\/10.1002\/jcph.2381","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"4116_CR76","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1093\/jac\/dkt229","volume":"68","author":"MJ Geist","year":"2013","unstructured":"Geist MJ, Egerer G, Burhenne J, Riedel KD, Weiss J, Mikus G (2013) Steady-state pharmacokinetics and metabolism of voriconazole in patients. J Antimicrob Chemother 68(11):2592\u20132599. https:\/\/doi.org\/10.1093\/jac\/dkt229","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"4116_CR77","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2165\/00003088-200645070-00002","volume":"45","author":"U Theuretzbacher","year":"2006","unstructured":"Theuretzbacher U, Ihle F, Derendorf H (2006) Pharmacokinetic\/pharmacodynamic profile of voriconazole. Clin Pharmacokinet 45(7):649\u2013663. https:\/\/doi.org\/10.2165\/00003088-200645070-00002","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"4116_CR78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/FTD.0b013e318167d0e0","volume":"30","author":"J Smith","year":"2008","unstructured":"Smith J, Andes D (2008) Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Ther Drug Monit 30(2):167\u2013172. https:\/\/doi.org\/10.1097\/FTD.0b013e318167d0e0","journal-title":"Ther Drug Monit"},{"key":"4116_CR79","doi-asserted-by":"publisher","unstructured":"Hanai Y, Hamada Y, Kimura T, Matsumoto K, Takahashi Y, Fujii S et al (2021) Favorable effects of voriconazole trough concentrations exceeding 1 \u00b5g\/ml on treatment success and all-cause mortality: a systematic review and meta-analysis. J fungi 7(4). https:\/\/doi.org\/10.3390\/jof7040306","DOI":"10.3390\/jof7040306"},{"issue":"7","key":"4116_CR80","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/phar.1779","volume":"36","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang T, Xie J, Yang Q, Zheng X, Dong W et al (2016) Risk factors for voriconazole-associated hepatotoxicity in patients in the intensive care unit. Pharmacotherapy 36(7):757\u2013765. https:\/\/doi.org\/10.1002\/phar.1779","journal-title":"Pharmacotherapy"},{"key":"4116_CR81","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.2147\/cia.S138535","volume":"12","author":"TD Filippatos","year":"2017","unstructured":"Filippatos TD, Makri A, Elisaf MS, Liamis G (2017) Hyponatremia in the elderly: challenges and solutions. Clin Interv Aging 12:1957\u20131965. https:\/\/doi.org\/10.2147\/cia.S138535","journal-title":"Clin Interv Aging"},{"issue":"2","key":"4116_CR82","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00000441-198602000-00007","volume":"291","author":"JD Semel","year":"1986","unstructured":"Semel JD, McNerney JJ Jr. (1986) SIADH during disseminated Herpes varicella-zoster infections: relationship to vidarabine therapy. Am J Med Sci 291(2):115\u2013118. https:\/\/doi.org\/10.1097\/00000441-198602000-00007","journal-title":"Am J Med Sci"},{"issue":"4","key":"4116_CR83","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1592\/phco.21.5.493.34488","volume":"21","author":"MM Chitre","year":"2001","unstructured":"Chitre MM, Berenson CS (2001) Idiosyncratic rifabutin-induced leukopenia and SIADH: case report and review. Pharmacotherapy 21(4):493\u2013497. https:\/\/doi.org\/10.1592\/phco.21.5.493.34488","journal-title":"Pharmacotherapy"},{"issue":"11","key":"4116_CR84","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1177\/106002809703101106","volume":"31","author":"RM Cadle","year":"1997","unstructured":"Cadle RM, Darouiche RO, Ashton CM (1997) Symptomatic syndrome of inappropriate antidiuretic hormone secretion associated with azithromycin. Annals pharmacotherapy 31(11):1308\u20131310. https:\/\/doi.org\/10.1177\/106002809703101106","journal-title":"Annals pharmacotherapy"},{"issue":"4","key":"4116_CR85","doi-asserted-by":"publisher","first-page":"e37607","DOI":"10.7759\/cureus.37607","volume":"15","author":"MO Sanni","year":"2023","unstructured":"Sanni MO, Rajkanna J, Sagi SV, Oyibo SO (2023) Syndrome of inappropriate antidiuretic hormone secretion (SIADH) complicated by generalized tonic-clonic seizures after a course of antibiotics: a case report. Cureus 15(4):e37607. https:\/\/doi.org\/10.7759\/cureus.37607","journal-title":"Cureus"},{"issue":"17\u201318","key":"4116_CR86","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00508-012-0220-3","volume":"124","author":"M Stuhec","year":"2012","unstructured":"Stuhec M, Svab V (2012) Nitrofurantoin-induced life-threatening seizures. Wiener klinische Wochenschrift 124(17\u201318):653\u2013654. https:\/\/doi.org\/10.1007\/s00508-012-0220-3","journal-title":"Wiener klinische Wochenschrift"},{"issue":"2","key":"4116_CR87","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/antibiotics12020240","volume":"12","author":"H Seo","year":"2023","unstructured":"Seo H, Kim E (2023) Electrolyte disorders associated with piperacillin\/tazobactam: a pharmacovigilance study using the FAERS database. Antibiot 12(2):240. https:\/\/doi.org\/10.3390\/antibiotics12020240. Published 2023 Jan 24","journal-title":"Antibiot (Basel)"},{"key":"4116_CR88","unstructured":"Cefdinir Induced Syndrome of Inappropriate Release of Antidiuretic Hormone. ScienceXcel (Journal of Clinical Cases) (2023) Available from Google Scholar"},{"key":"4116_CR89","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000493246","volume":"52","author":"G Liamis","year":"2019","unstructured":"Liamis G, Megapanou E, Elisaf M, Milionis H (2019) Hyponatremia-inducing drugs. Front Horm Res 52:167\u2013177. https:\/\/doi.org\/10.1159\/000493246","journal-title":"Front Horm Res"},{"issue":"1","key":"4116_CR90","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/j.ajkd.2008.03.004","volume":"52","author":"G Liamis","year":"2008","unstructured":"Liamis G, Milionis H, Elisaf M (2008) A review of drug-induced hyponatremia. Am J kidney diseases: official J Natl Kidney Foundation 52(1):144\u2013153. https:\/\/doi.org\/10.1053\/j.ajkd.2008.03.004","journal-title":"Am J kidney diseases: official J Natl Kidney Foundation"},{"issue":"15","key":"4116_CR91","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.3390\/ijerph17155320","volume":"17","author":"AL Kr\u00f3licka","year":"2020","unstructured":"Kr\u00f3licka AL, Kruczkowska A, Krajewska M, Kusztal MA (2020) Hyponatremia in infectious diseases\u2014a literature review. Int J Environ Res Public Health 17(15):5320","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"4116_CR92","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239\u2013245","journal-title":"Clin Pharmacol Ther"},{"issue":"10 Suppl 1","key":"4116_CR93","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","volume":"126","author":"JG Verbalis","year":"2013","unstructured":"Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH et al (2013) Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 126(10 Suppl 1):S1\u201342. https:\/\/doi.org\/10.1016\/j.amjmed.2013.07.006","journal-title":"Am J Med"},{"issue":"8","key":"4116_CR94","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/eci.12465","volume":"45","author":"P Grant","year":"2015","unstructured":"Grant P, Ayuk J, Bouloux PM, Cohen M, Cranston I, Murray RD et al (2015) The diagnosis and management of inpatient hyponatraemia and SIADH. Eur J Clin Invest 45(8):888\u2013894. https:\/\/doi.org\/10.1111\/eci.12465","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"4116_CR95","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1210\/endrev\/bnad010","volume":"44","author":"AM Warren","year":"2023","unstructured":"Warren AM, Grossmann M, Christ-Crain M, Russell N (2023) Syndrome of inappropriate antidiuresis: from pathophysiology to management. Endocr Rev 44(5):819\u2013861. https:\/\/doi.org\/10.1210\/endrev\/bnad010","journal-title":"Endocr Rev"},{"issue":"8","key":"4116_CR96","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1210\/clinem\/dgac245","volume":"107","author":"J Martin-Grace","year":"2022","unstructured":"Martin-Grace J, Tomkins M, O\u2019Reilly MW, Thompson CJ, Sherlock M (2022) Approach to the patient: hyponatremia and the syndrome of inappropriate antidiuresis (SIAD). J Clin Endocrinol Metab 107(8):2362\u20132376. https:\/\/doi.org\/10.1210\/clinem\/dgac245","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4116_CR97","first-page":"299","volume":"91","author":"MM Braun","year":"2015","unstructured":"Braun MM, Barstow CH, Pyzocha NJ (2015) Diagnosis and management of sodium disorders: hyponatremia and hypernatremia. Am Fam Physician 91(5):299\u2013307","journal-title":"Am Fam Physician"},{"issue":"3","key":"4116_CR98","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.amjmed.2012.06.037","volume":"126","author":"G Liamis","year":"2013","unstructured":"Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH, Hoorn EJ (2013) Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med 126(3):256\u2013263","journal-title":"Am J Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04116-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04116-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04116-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:57:21Z","timestamp":1783929441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04116-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":98,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4116"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04116-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations of interest"}}],"article-number":"179"}}